What Researchers Did
Researchers investigated how a series of hyperbaric oxygen treatments affected chromosome changes in the blood cells of 7 patients with various conditions and 3 healthy volunteers.
What They Found
The study found that after hyperbaric oxygen therapy, the frequency of chromatid-type chromosome aberrations remained largely unchanged. However, the frequency of chromosome-type aberrations significantly decreased by three times overall.
What This Means for Canadian Patients
This early research suggests a potential cellular benefit of hyperbaric oxygen therapy by reducing certain types of chromosome damage. While not directly linked to a specific HBOT-treatable condition, it hints at possible protective effects at a cellular level. Further modern research would be needed to understand clinical implications for patients.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study involved a very small number of participants and was conducted over 30 years ago, limiting its generalizability and modern clinical applicability.